Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red blood cell polyagglutination: clinical aspects.

M L Beck1

  • 1Community Blood Center of Greater Kansas City, MO 64111, USA.

Seminars in Hematology
|May 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal and spatial genetic variability in white-tailed deer (Odocoileus virginianus).

Genetica·2004
Same author

The Lutheran blood group system: a review.

Immunohematology·2004
Same author

Monoclonal antibodies as blood grouping reagents.

Immunohematology·2004
Same author

Karyotypic analysis of the cotton boll weevil, Anthonomus grandis Boheman.

Genetica·2001
Same author

Transplantation rate of the blood group B waiting list is increased by using A2 and A2B kidneys.

Transplantation·1999
Same author

Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin-T immunoassays.

Research in veterinary science·1998

Polyagglutination occurs when red blood cells (RBCs) react with most adult human sera due to exposed antigens. This can be transient, caused by infections, or persistent, linked to genetic factors or hematologic disorders.

Area of Science:

  • Hematology
  • Immunology
  • Genetics

Background:

  • Polyagglutination describes red blood cells (RBCs) agglutinated by most adult human sera, but not autologous serum or newborn sera.
  • This RBC condition can be transient, often due to bacterial enzymatic activity during infections, or persistent, stemming from genetic or hematologic issues.

Purpose of the Study:

  • To define and differentiate the causes and characteristics of transient and persistent polyagglutination.
  • To elucidate the immunological and enzymatic mechanisms underlying antigen exposure in polyagglutination.

Main Methods:

  • Review of clinical cases and laboratory findings associated with polyagglutination.
  • In vitro studies using bacterial culture fluids and isolated enzymes to induce transient polyagglutination.

Related Experiment Videos

  • Analysis of genetic and hematologic profiles in persistent polyagglutination cases.

    • Main Results:

    • Transient polyagglutination results from bacterial enzymes exposing cryptic RBC antigens, which are recognized by adult human sera.
    • Persistent polyagglutination can arise from somatic mutations (e.g., Tn polyagglutination) or inherited blood groups, often associated with leukopenia, thrombocytopenia, and leukemia.
    • Tn polyagglutination involves exposure of a cryptic antigen recognized by anti-Tn antibodies present in most adult sera.

    Conclusions:

    • Polyagglutination is a complex phenomenon with distinct transient and persistent forms, each with unique etiologies and clinical implications.
    • Understanding the mechanisms of antigen exposure is crucial for diagnosing and managing polyagglutination, especially when associated with hematologic disorders.